Highlights |
|
HIV Self-Test Kits and Prevention Tools: CDC’s Dr. Neblett Fanfair on 2024 CROI Highlights
HIV.gov | March 15, 2024
|
|
HIV.gov Blog: Week in Review - CROI 2024 Special Edition
HIV.gov | March 15, 2024
|
|
CROI 2024 Highlights: Conference on Retroviruses and Opportunistic Infections
ADAP | March 14, 2024
|
|
CDC’s Dr. Mermin Discusses HIV & STI Prevention Highlights from CROI 2024
HIV.gov | March 13, 2024
|
|
HIV Treatment Research and Key Takeaways: Dr. Dieffenbach's Final Update from CROI 2024
HIV.gov | March 8, 2024
|
|
Monthly ART Injections Top Pills for HIV Patients With Adherence Problems
Medpage Today | March 8, 2024
|
|
CROI2024: Day 3 Recap
HIV.gov | March 6, 2024
|
|
Children surpass a year of HIV remission after treatment pause
NIH | March 6, 2024
|
|
CROI2024: Day 1 Recap
HIV.gov | March 4, 2024
|
|
WHO @ CROI 2024
WHO | March 3-7 2024
|
|
|
Medication |
|
PrEP Non-Persistence and New HIV Diagnoses: A Real-World Analysis of >120,000 People Prescribed PrEP
NATAP | CROI 2024 March 3-6 Denver
|
|
US States With More PrEP Coverage See Bigger Drops in HIV Diagnoses
NATAP | CROI 2024 March 3-6 Denver
|
|
Why Is Cabotegravir Rollout So Slow?
NATAP | CROI 2024 March 3-6 Denver
|
|
Semaglutide Effective for Metabolic-Associated Steatotic Liver Disease in HIV
Infectious Disease Advisor | March 21, 2024
|
|
Long-Acting ART for HIV Favored in Patients With Suboptimal Treatment Adherence
Infectious Disease Advisor | March 21, 2024
|
|
People who struggle with daily HIV regimen should be offered long-acting injections
Healio | March 9, 2024
|
|
Watch HIV Researchers at CROI 2024 Discuss New Options for Long-Acting Treatment
POZ Magazine | March 8, 2024
|
|
HIV Treatment Research and Key Takeaways: Dr. Dieffenbach’s Final Update from CROI 2024
HIV.gov | March 8, 2024
|
|
New Once-Daily HIV Oral Alternative Advances
Medscape | March 8, 2024
|
|
ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva compared to...
MarketScreener | March 7, 2024
|
|
Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV
NIH | March 6, 2024
|
|
Once-weekly antiretrovirals on the horizon
Aidsmap | March 6, 2024
|
|
Investigational two-drug regimen safe, effective for patients with HIV
Healio | CROI2024 | March 6, 2024
|
|
Dapivirine ring and oral PrEP found safe for preventing HIV in pregnant women
Contemporary OB/GYN | March 6, 2024
|
|
PrEP use up, HIV incidence down, data show
Healio | CROI2024 | March 5, 2024
|
|
Phase 1 Study of Cabotegravir Long-Acting Injectable Formulations Supports ≥4-Monthly Dose Interval
CROI | CROI 2024 March 3-6 Denver
|
|
|
|
News |
|
A Randomized Trial Switching Adults ≥ 60 Years Old From First-Line ART to B/F/TAF: Week 48 Results
NATAP | CROI 2024 March 3-6 Denver
|
|
Disparities in HIV care among Hispanic/Latino persons by birthplace and social vulnerability-United States, 2021
NATAP | CROI 2024 March 3-6 Denver
|
|
Using the ICE Method to Examine Income/Racial Segregation and HIV Outcomes -US, 2021: structural racism
NATAP | CROI 2024 March 3-6 Denver
|
|
Community Advocates at #CROI2024 Condemn Appalling Behavior by Hundreds of Opening Plenary Attendees
EATG | March 7, 2024
|
|
|
Mental Health |
|
TRENDS IN SUICIDE-RELATED EMERGENCY DEPARTMENT VISITS AMONG PEOPLE WITH AND WITHOUT HIV IN BRONX, NY
CROI 2024 March 3-6 Denver | courtesy of NATAP.org
|
|
|
Testing & Prevention |
|
National HIV self-testing program finds high demand, many testing for first time
Healio | CROI | March 15, 2024
|
|
|
HIV & Aging |
|
Age Modifies the Association Between Sex and the Plasma Inflammatory Proteome in Treated HIV
CROI 2024 March 3-6 Denver | courtesy of NATAP.org
|
|
Age-Adjusted Mortality Rates Among Persons With HIV, by Race and Ethnicity and Cause of Death....22% due to comorbidities
NATAP | CROI 2024 March 3-6 Denver
|
|
|
COVID-19 |
|
Dexamethasone Plus Remdesivir Dual Therapy Reduces Mortality in COVID-19
Infectious Disease Advisor | March 21, 2024
|
|
Study reveals why COVID-19 antibodies fade quickly
News Medical | March 18, 2024
|
|
COVID-19 hybrid immunity more protective than vaccination alone among people with HIV
Healio | CROI | March 13, 2024
|
|
SARS-CoV-2 protein detectable in COVID-19 patients up to 14 months after illness
Healio | CROI | March 4, 2024
|
|
|
Youth |
|
Data Support Use of Long-Acting Antiretroviral Therapy in Adolescents With HIV
Infectious Disease Advisor | March 21, 2024
|
|
Four children achieve treatment-free HIV remission for 1 year
Healio | CROI2024 | March 8, 2024
|
|
HIV Scientists at CROI 2024 Discuss a Promising Study on Newborns
POZ | March 8, 2024 |
|
Study Shows Promising Outcomes with HIV Treatment Started Promptly After Birth
HIV.gov | March 7, 2024
|
|
NIH study finds long-acting ART safe for HIV suppression in adolescents
Contemporary OB/GYN | March 7, 2024
|
|
Children Surpass a Year of HIV Remission after Treatment Pause
NIH | March 6, 2024 |
|
Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy
Johns Hopkins Medicine | March 6, 2024 |
|
Injectable ART given every 8 weeks safely suppresses HIV in adolescents
Healio | CROI2024 | March 6, 2024
|
|
|
Medical |
|
Immunologic Factors Tied to Mpox Hospitalization Risk in Patients With HIV
Infectious Disease Advisor | March 21, 2024
|
|
2024 CROI Tuberculosis Research Round Up
TAG | March 14, 2024
|
|
Associations between Nadir CD4 and Subsequent Immune Measures with Long-Term Cognitive Function in HAILO (ACTG 5322)
NATAP | CROI 2024 March 3-6 Denver
|
|
Modifiable Factors Associated With Cardiovascular Disease Risk Among Women With and Without HIV
CROI 2024 March 3-6 Denver | courtesy of NATAP.org
|
|
InSTI Switch During Menopause Is Associated With Accelerated Body Composition Change
NATAP | CROI 2024 March 3-6 Denver
|
|
Tools Underestimate Cardiovascular Event Risk in People with HIV
HIV.gov | March 4, 2024 |
|
Addressing Liver and Cardiovascular Disease among People with HIV and HIV Prevention During Pregnancy: Dr. Dieffenbach’s Second Update...
HIV.gov | March 6, 2024
|
|
|
|